Scholarlink

Objective <p>To investigate the role of lncRNA GAS5 in COPD and its underlying mechanism.</p> Methods <p>COPD mouse model was conducted as an in vivo inflammatory response model. CSE was used to stimulate human airway epithelial cells (16HBE) and human normal lung epithelial cells (BEAS-2B) to establish an in vitro inflammatory response model. Recombinant adenoviruses containing GAS5 or GAS5 shRNA were used to overexpression or knockdown of GAS5. The expression of p120/NF-κB was detected by RT-PCR and Western Blot. The distribution of NF-κB p65 protein in cells was detected by western blot and immunofluorescence staining. The expression levels of IL-6, IL-8 and TNF-α in downstream NF-κB were detected by RT-PCR and ELISA.</p> Result <p>The expression of lncRNA GAS5 was downregulated in COPD in vivo and in vitro. We showed that overexpression of GAS5 alleviates inflammation and NF-κB activation in COPD in vivo and in vitro. Moreover, we demonstrated that GAS5 regulate NF-κB activation by bind with p120. Knocking down of p120 inhibits the protective effect of GAS5 on inflammation.</p> Conclusion <p>LncRNA GAS5 can bind with p120, enhance p120 stability and inhibit the NF-κB pathway and production of inflammatory factors downstream of NF-κB, thus playing a protective role in the airway.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

LncRNA GAS5 attenuates COPD pathogenesis by stabilizing p120 catenin to suppress NF-κB-driven inflammation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月6日

查看全文
  • Chao Zhang,
  • Xiaoqian Zhan,
  • Yue Li,
  • Zhe Zheng,
  • Xiaoyang Ji,
  • Liuye Yang,
  • Xi Wang

摘要

Objective

To investigate the role of lncRNA GAS5 in COPD and its underlying mechanism.

Methods

COPD mouse model was conducted as an in vivo inflammatory response model. CSE was used to stimulate human airway epithelial cells (16HBE) and human normal lung epithelial cells (BEAS-2B) to establish an in vitro inflammatory response model. Recombinant adenoviruses containing GAS5 or GAS5 shRNA were used to overexpression or knockdown of GAS5. The expression of p120/NF-κB was detected by RT-PCR and Western Blot. The distribution of NF-κB p65 protein in cells was detected by western blot and immunofluorescence staining. The expression levels of IL-6, IL-8 and TNF-α in downstream NF-κB were detected by RT-PCR and ELISA.

Result

The expression of lncRNA GAS5 was downregulated in COPD in vivo and in vitro. We showed that overexpression of GAS5 alleviates inflammation and NF-κB activation in COPD in vivo and in vitro. Moreover, we demonstrated that GAS5 regulate NF-κB activation by bind with p120. Knocking down of p120 inhibits the protective effect of GAS5 on inflammation.

Conclusion

LncRNA GAS5 can bind with p120, enhance p120 stability and inhibit the NF-κB pathway and production of inflammatory factors downstream of NF-κB, thus playing a protective role in the airway.